- $199.38m
- $184.09m
- $64.00m
- 99
- 47
- 82
- 90
Annual income statement for Electromed, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 35.8 | 41.7 | 48.1 | 54.7 | 64 |
| Cost of Revenue | |||||
| Gross Profit | 27.3 | 31.4 | 36.5 | 41.7 | 50 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32.6 | 38.7 | 44.1 | 48.1 | 54.3 |
| Operating Profit | 3.14 | 2.97 | 4.01 | 6.58 | 9.66 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.17 | 3 | 4.09 | 7.04 | 10.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.36 | 2.31 | 3.17 | 5.15 | 7.54 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.36 | 2.31 | 3.17 | 5.15 | 7.54 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.36 | 2.31 | 3.17 | 5.15 | 7.54 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.265 | 0.263 | 0.364 | 0.581 | 0.863 |